Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Orchard Therapeutics plc (ORTX)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jun-30-23 | Jun-05-23 | Mar-31-23 | Mar-05-23 | Dec-31-22 | Dec-05-22 | Sep-30-22 | Jun-30-22 |
| | 10-Q | 8-K | 10-Q | 8-K | 10-K | 8-K | 10-Q | 10-Q |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 29.9% | 29.9% | 29.7% | 29.7% | 34.8% | 34.8% | 28.5% | 25.7% |
| Gross profit | 70.1% | 70.1% | 70.3% | 70.3% | 65.2% | 65.2% | 71.5% | 74.3% |
| Selling, general and administrative | 378.5% | 150.3% | 2193.0% | 900.2% | | 151.7% | 512.4% | 817.2% |
| Research and development | | | | | | | | |
| General and administrative | | | | | 517.4% | | | |
| EBITDA | -18.4% | -308.5% | -953.8% | -2122.7% | 204.5% | -452.2% | -1232.1% | -1583.4% |
| Depreciation | 9.0% | | 52.0% | | 10.3% | | 11.3% | 15.0% |
| EBIT | -27.4% | -308.5% | -1005.8% | -2122.7% | 194.2% | -452.2% | -1243.4% | -1598.5% |
| Pre-tax income | -167.9% | -167.9% | -1408.6% | -1408.6% | -129.0% | -129.0% | -842.1% | -1170.7% |
| Income taxes | 0.3% | 0.0% | -1.0% | -1.0% | -16.2% | -16.2% | -18.8% | -5.0% |
| Net income | -168.3% | 0.0% | -1407.6% | -1407.6% | -112.8% | -112.8% | -823.4% | -1165.7% |
|